CORE TEAM

Wang Jinjing

Master of Bioengineering, Founder and Chairman of the Fukangren group
He has rich experience in the R&D of innovative drugs, high-end preparations and super generic drugs
Actively involved in the domestic and foreign pharmaceutical markets for more than 20 years
Rich experience in life science business development management.

Zhao Kang

Partner
Doctor of Chemistry, the first Changjiang Scholar
Chief scientist of Novartis
Dean, School of Pharmacy, Tianjin University
Columbia UnChairman of the New York Academy of Sciences Uiversity Professor

Zhong Bohua

Co-founder
Chief scientist of innovative drug synthesis
Former researcher and doctoral tutor at the Institute of Pharmacology and Toxicology, Academy of Military Medical Sciences

Cheng Changmei

Partner
Chemical synthesis consultant
Professor, Department of Chemistry, University of Tokyo, Tsinghua University, Ph.D.

Nie Aihua

Fu Kangren Jinan General Manager
Director of synthesis
Former researcher and doctoral tutor at the Institute of Pharmacology and Toxicology, Academy of Military Medical Sciences

Mei Xingguo

Professor Mei Xingguo
Yan Kangren Jinan Preparation Director
Director of the Pharmacy Department of the former Academy of Military Medical Sciences

Yan Yidong

Dr. Yan Yidong
General Manager Kang Kangren
Director of Preparations
Doctor of Pharmaceutical Preparation, Lingnan University, Korea

Technical Services

As a prominent China based R&D company, we provide the flexible comprehensive range of services and customized solutions. Our team bring together fundamentals, rich experience and innovative technical expertise. We mainly provide Product development services for generic and specialty pharmaceuticals with professional standard. Our main services include:

? Product Selection, Product development, and Method development

? Formulation Development, Formulation Analysis & BE Study

? Trial Batch and Commercial Batch Production and Technology Transfer

? Dossier Preparation & Registration

? Portfolio Management

CDMO

CDMO - API

CDMO - API division at Fukangren is well experienced with proven track record of the of API development, scale up and commercialization. Fukangren is proud to offer the end to end CDMO services for the API:

§ Drug substance value chain from routes of synthesis to commercialization

§ Immense Planning, Security and Treasured synergy effects in development

§ Patent Evaluation and Protection for the projects

§ Dedicated regulatory team for dossier preparation

§ Devoted unit for tech transfer and scale up activities

§ Extensive strategic relationships with access to large commercial facility

CDMO: FDF

FDF(Finished Dosage Forms) section in the CDMO unit has impeccable record of drug development, scale up and Industrial production. Fukangren is happy to offer the complete CDMO services for the FDF with bespoke team, single point of contact and tailor-made process:

§ Full service: R&D, Clinical study, pilot and commercial production and regulatory filings

§ Integrated capabilities and specialized expertise for the pipeline development

§ Formulation Conception & creation, Formulation selection and development

§ Large production capacities, Advanced tools and technologies

§ Multiple facilities for alternatives and back up

§ Cost effective Manufacturing Solutions

§ Track record of product quality, On time delivery, Regulatory Compliance, and Safety

About US